On October 25, 2017 Juno Therapeutics, Inc. (NASDAQ: JUNO) reported that it will announce financial results for the third quarter 2017 on Wednesday, November 1, 2017, after the close of U.S.-based financial markets (Press release, Juno, OCT 25, 2017, View Source [SID1234521171]). Following the announcement, Juno management will host a conference call and live webcast to provide a business update and discuss financial results beginning at 1:30 p.m. Pacific Time (PT) / 4:30 p.m. Eastern Time (ET).

Analysts and investors can participate in the conference call by dialing (855) 780-7198 for domestic callers and (631) 485-4870 for international callers, using the conference ID# 2899809.
The webcast can be accessed live on the Investor Relations page of Juno’s website, www.JunoTherapeutics.com, and will be available for replay for 30 days following the call.